Background Increasing evidence supporting the value of screening women for cervical cancer once in their lifetime, coupled with mounting interest in scaling up successful screening demonstration projects, present challenges to public health decision makers seeking to take full advantage of the single-visit opportunity to provide additional services. We present an analytic framework for packaging multiple interventions during a single point of contact, explicitly taking into account a budget and scarce human resources, constraints acknowledged as significant obstacles for provision of health services in poor countries. Methods and Findings We developed a binary integer programming (IP) model capable of identifying an optimal package of health services to be provided during a single visit for a particular target population. Inputs to the IP model are derived using state-transition models, which compute lifetime costs and health benefits associated with each intervention. In a simplified example of a single lifetime cervical cancer screening visit, we identified packages of interventions among six diseases that maximized disability-adjusted life years (DALYs) averted subject to budget and human resource constraints in four resource-poor regions. Data were obtained from regional reports and surveys from the World Health Organization, international databases, the published literature, and expert opinion. With only a budget constraint, interventions for depression and iron deficiency anemia were packaged with cervical cancer screening, while the more costly breast cancer and cardiovascular disease interventions were not. Including personnel constraints resulted in shifting of interventions included in the package, not only across diseases but also between low- and high-intensity intervention options within diseases. Conclusions The results of our example suggest several key themes: Packaging other interventions during a one-time visit has the potential to increase health gains; the shortage of personnel represents a real-world constraint that can impact the optimal package of services; and the shortage of different types of personnel may influence the contents of the package of services. Our methods provide a general framework to enhance a decision maker's ability to simultaneously consider costs, benefits, and important nonmonetary constraints. We encourage analysts working on real-world problems to shift from considering costs and benefits of interventions for a single disease to exploring what synergies might be achievable by thinking across disease
References
[1]
Goodburn E, Campbell O (2001) Reducing maternal mortality in the developing world: Sector-wide approaches may be the key. BMJ 322: 917–920.
[2]
World Health Organization (2002) The World Health Report 2002: Reducing risks, promoting healthy life. Geneva: WHO. 230 p.
[3]
Yang BH, Bray FI, Parkin DM, Sellors JW, Zhang ZF (2004) Cervical cancer as a priority for prevention in different world regions: An evaluation using years of life lost. Int J Cancer 109: 418–424.
[4]
Denny L, Kuhn L, De Souza M, Pollack AE, Dupree W, et al. (2005) Screen-and-treat approaches for cervical cancer prevention in low-resource settings: A randomized controlled trial. JAMA 294: 2173–2181.
[5]
Blumenthal PD, Gaffikin L (2005) Cervical cancer prevention: Making programs more appropriate and pragmatic. JAMA 294: 2225–2228.
[6]
Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, Gordillo-Tobar A, Levin C, et al. (2005) Cost-effectiveness of cervical cancer screening in five developing countries. N Engl J Med 353: 2158–2168.
[7]
Schiffman M, Castle PE (2005) The promise of global cervical-cancer prevention. N Engl J Med 353: 2101–2104.
[8]
Goldie SJ, Kuhn L, Denny L, Pollack A, Wright TC (2001) Policy analysis of cervical cancer screening strategies in low-resource settings: Clinical benefits and cost-effectiveness. JAMA 285: 3107–3115.
[9]
Nullis-Kapp C (2005) Health worker shortage could derail development goals. Bull World Health Organ 83: 5–6.
[10]
Hongoro C, McPake B (2004) How to bridge the gap in human resources for health. Lancet 364: 1451–1456.
[11]
Kober K, Van Damme W (2004) Scaling up access to antiretroviral treatment in southern Africa: Who will do the job? Lancet 364: 103–107.
[12]
Bobadilla JL, Cowley P (1995) Designing and implementing packages of essential health services. J Int Development 7: 543–554.
[13]
Murray CJ (1994) Quantifying the burden of disease: The technical basis for disability-adjusted life years. Bull World Health Organ 72: 429–445.
[14]
Brugha R, Donoghue M, Starling M, Ndubani P, Ssengooba F, et al. (2004) The Global Fund: Managing great expectations. Lancet 364: 95–100.
[15]
Barton MB, Harris R, Fletcher SW (1999) The rational clinical examination. Does this patient have breast cancer? The screening clinical breast examination: Should it be done? How? JAMA 282: 1270–1280.
[16]
Bobo JK, Lee NC, Thames SF (2000) Findings from 752,081 clinical breast examinations reported to a national screening program from 1995 through 1998. J Natl Cancer Inst 92: 971–976.
[17]
Humphrey LL, Helfand M, Chan BK, Woolf SH (2002) Breast cancer screening: A summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 137: 347–360.
[18]
Denny L, Kuhn L, Pollack A, Wainwright H, Wright TC Jr. (2000) Evaluation of alternative methods of cervical cancer screening for resource-poor settings. Cancer 89: 826–833.
[19]
Kuhn L, Denny L, Pollack A, Lorincz A, Richart RM, et al. (2000) Human papillomavirus DNA testing for cervical cancer screening in low-resource settings. J Natl Cancer Inst 92: 818–825.
[20]
Sankaranarayanan R, Basu P, Wesley RS, Mahe C, Keita N, et al. (2004) Accuracy of visual screening for cervical neoplasia: Results from an IARC multicentre study in India and Africa. Int J Cancer 110: 907–913.
[21]
Sankaranarayanan R, Budukh AM, Rajkumar R (2001) Effective screening programmes for cervical cancer in low- and middle-income developing countries. Bull World Health Organ 79: 954–962.
[22]
Sankaranarayanan R, Chatterji R, Shastri SS, Wesley RS, Basu P, et al. (2004) Accuracy of human papillomavirus testing in primary screening of cervical neoplasia: Results from a multicenter study in India. Int J Cancer 112: 341–347.
[23]
Patten SB, Brandon-Christie J, Devji J, Sedmak B (2000) Performance of the Composite International Diagnostic Interview Short Form for major depression in community and clinical samples. Chronic Dis Can 21: 68–72.
[24]
Sari M, de Pee S, Martini E, Herman S, Sugiatmi , et al. (2001) Estimating the prevalence of anaemia: A comparison of three methods. Bull World Health Organ 79: 506–511.
[25]
Law MR, Wald NJ, Morris JK (2004) The performance of blood pressure and other cardiovascular risk factors as screening tests for ischaemic heart disease and stroke. J Med Screen 11: 3–7.
[26]
Pettifor A, Walsh J, Wilkins V, Raghunathan P (2000) How effective is syndromic management of STDs?: A review of current studies. Sex Transm Dis 27: 371–385.
[27]
Watson EJ, Templeton A, Russell I, Paavonen J, Mardh PA, et al. (2002) The accuracy and efficacy of screening tests for : a systematic review. J Med Microbiol 51: 1021–1031.
[28]
Schwebke JR, Sadler R, Sutton JM, Hook EW 3rd (1997) Positive screening test for gonorrhea and chlamydial infection fail to lead consistently to treatment of patients attending sexually transmitted disease clinic. Sex Transm Dis 24: 181–184.
[29]
Gold MR, Siegel JE, Russel LB, Weinstein MC (1996) Cost-effectiveness in health care and medicine. New York: Oxford University Press.
[30]
Musgrove P, Zeramdini R, Carrin G (2002) Basic patterns of national health expenditures. Bull World Health Organ 80: 134–142.
[31]
Stinnett AA, Paltiel AD (1996) Mathematical programming for the efficient allocation of health care resources. J Health Econ 15: 641–653.
[32]
Earnshaw SR, Dennett SL (2003) Integer/linear mathematical programming models: A tool for allocating healthcare resources. Pharmacoeconomics 21: 839–851.
[33]
Chen MM, Bush JW (1976) Maximizing health system output with political and administrative constraints using mathematical programming. Inquiry 13: 215–227.
[34]
Wang LY, Haddix AC, Teutsch SM, Caldwell B (1999) The role of resource allocation models in selecting clinical preventive services. Am J Manag Care 5: 445–454.
[35]
Tao G, Abban BK, Gift TL, Chen G, Irwin KL (2004) Applying a mixed-integer program to model re-screening women who test positive for infection. Health Care Manag Sci 7: 135–144.
[36]
Granata AV, Hillman AL (1998) Competing practice guidelines: Using cost-effectiveness analysis to make optimal decisions. Ann Intern Med 128: 56–63.
[37]
Lorincz A, Eder P, Sellors J, Nazarenko (2004) Creation of an HPV test for developing countries. 2004 21–23 October; EUROGIN 2004 International Expert Meeting, Nice. pp. PS4–6.
[38]
Bryce J, Black RE, Walker N, Bhutta ZA, Lawn JE, et al. (2005) Can the world afford to save the lives of 6 million children each year? Lancet 365: 2193–2200.
[39]
Williams A (1999) Calculating the global burden of disease: Time for a strategic reappraisal? Health Econ 8: 1–8.
[40]
Murray CJ, Lopez AD (2000) Progress and directions in refining the global burden of disease approach: A response to Williams. Health Econ 9: 69–82.
